Identification of deleterious mutation in CHEK2 gene an insilico approach

被引:0
|
作者
Punyadeep [1 ]
Singh, Priyanka [1 ]
Sudandiradoss, C. [1 ]
机构
[1] VIT Univ, Sch Biol Sci & Technol, Vellore 632014, Tamil Nadu, India
来源
HELIX | 2012年 / 3卷
关键词
CHEK2; gene; SIFT; PolyPhen; I-Mutant;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Single-nucleotide polymorphisms (SNPs) play a major role in the understanding of the genetic basis of many complex human diseases. The current study reports. of the total of 682 SNPs in the CHK2 gene. 10 non-svnonvmous SNPs (nsSNPs) were identified as functionally significant. SIFT, PolyPhen and I -Mutant programs were used to analyze the nsSNPs. Out of total 10 nsSNPs, 8 were found to be deleterious by SIFT and 5 were damaging as per the PolyPhen program. The complete analysis of these mutations has been the focus of the paper. The structural stability of the mutated structures was studied using I- Mutant program. From a comparison of the stabilizing residues of the native and mutant proteins. we propose that the nsSN P rs121908706. rs121908705, rs121908701, rs112032633and rs111292981) could be important candidates for the various cancers caused by the mutation in CHEK2 gene.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [1] Polyposis With a Mutation in the CHEK2 Tumor Suppressor Gene
    Greenberg, Ian
    Khan, Omar
    DePersia, Allison
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S938 - S938
  • [2] Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
    Kleiblova, Petra
    Stolarova, Lenka
    Krizova, Katerina
    Lhota, Filip
    Hojny, Jan
    Zemankova, Petra
    Havranek, Ondrej
    Vocka, Michal
    Cerna, Marta
    Lhotova, Klara
    Borecka, Marianna
    Janatova, Marketa
    Soukupova, Jana
    Sevcik, Jan
    Zimovjanova, Martina
    Kotlas, Jaroslav
    Panczak, Ales
    Vesela, Kamila
    Cervenkova, Jana
    Schneiderova, Michaela
    Burocziova, Monika
    Burdova, Kamila
    Stranecky, Viktor
    Foretova, Lenka
    Machackova, Eva
    Tavandzis, Spiros
    Kmoch, Stanislav
    Macurek, Libor
    Kleibl, Zdenek
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1782 - 1797
  • [3] Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germline mutation and non-CHEK2 somatic mutation gene signatures
    Ow, Ghim Siong
    Ivshina, Anna V.
    Fuentes, Gloria
    Kuznetsov, Vladimir A.
    CELL CYCLE, 2014, 13 (14) : 2262 - 2280
  • [4] The analysis of CHEK2 gene mutation in small cell lung cancer
    Nizamova, Aigool
    Gimalova, Galiya
    Abdullin, Zamir
    Khusnutdinova, Elsa
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Recurrent Acromegaly in a Patient With a CHEK2 Mutation
    Perosevic, Milica
    Martinez-Lage, Maria
    Swearingen, Brooke
    Tritos, Nicholas A.
    AACE CLINICAL CASE REPORTS, 2022, 8 (02): : 85 - 88
  • [6] CHEK2 mutation and hereditary breast cancer
    Narod, Steven A.
    Lynch, Henry T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 6 - 7
  • [7] CHEK2 mutation and hereditary breast cancer
    Bogdanova, Natalia
    Feshchenko, Sergei
    Cybulski, Cezary
    Doerk, Thilo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : E26 - E26
  • [8] CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA
    Shah, Nidhi
    Walter, Andrew
    NEURO-ONCOLOGY, 2018, 20 : 120 - 120
  • [9] CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA
    Shah, Nidhi
    Walter, Andrew
    NEURO-ONCOLOGY, 2018, 20 : 170 - 171
  • [10] Skin cancer risk in CHEK2 mutation carriers
    Bui, A. N.
    LeBoeuf, N. R.
    Nambudiri, V. E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : 353 - 359